Teyi Pharmaceutical Group Co Ltd (002728) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.029x

Based on the latest financial reports, Teyi Pharmaceutical Group Co Ltd (002728) has a cash flow conversion efficiency ratio of 0.029x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.94 Million ≈ $7.75 Million USD) by net assets (CN¥1.84 Billion ≈ $269.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Teyi Pharmaceutical Group Co Ltd (002728) liquidity interval to measure how many days the company can operate on defensive assets alone.

Teyi Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Teyi Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Teyi Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Teyi Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cracker Barrel Old Country Store NASDAQ:CBRL	0.221x
Fujian Yongfu Power Engineering Co Ltd Class A SHE:300712	0.100x
Bide Pharmatech Co. Ltd. A SHG:688073	N/A
ZJAMP Group Co Ltd SHE:002758	0.072x
HealthStream Inc NASDAQ:HSTM	0.037x
Echo Investment SA WAR:ECH	0.140x
Harbin Jiuzhou Electrical Co Ltd SHE:300040	0.108x
Daewon Cable KO:006340	-0.036x

Annual Cash Flow Conversion Efficiency for Teyi Pharmaceutical Group Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Teyi Pharmaceutical Group Co Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see 002728 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.84 Billion ≈ $269.06 Million	CN¥244.88 Million ≈ $35.83 Million	0.133x	+1142.38%
2024-12-31	CN¥1.76 Billion ≈ $258.27 Million	CN¥-22.55 Million ≈ $-3.30 Million	-0.013x	-112.94%
2023-12-31	CN¥2.01 Billion ≈ $294.23 Million	CN¥198.56 Million ≈ $29.06 Million	0.099x	-62.72%
2022-12-31	CN¥1.40 Billion ≈ $205.32 Million	CN¥371.66 Million ≈ $54.39 Million	0.265x	+30.13%
2021-12-31	CN¥1.26 Billion ≈ $184.62 Million	CN¥256.81 Million ≈ $37.58 Million	0.204x	+30.14%
2020-12-31	CN¥1.08 Billion ≈ $158.10 Million	CN¥168.99 Million ≈ $24.73 Million	0.156x	-18.63%
2019-12-31	CN¥1.15 Billion ≈ $168.73 Million	CN¥221.64 Million ≈ $32.43 Million	0.192x	+13.64%
2018-12-31	CN¥1.11 Billion ≈ $162.60 Million	CN¥187.97 Million ≈ $27.51 Million	0.169x	+71.34%
2017-12-31	CN¥1.04 Billion ≈ $152.60 Million	CN¥102.96 Million ≈ $15.07 Million	0.099x	-13.59%
2016-12-31	CN¥886.57 Million ≈ $129.73 Million	CN¥101.30 Million ≈ $14.82 Million	0.114x	+33.44%
2015-12-31	CN¥804.30 Million ≈ $117.69 Million	CN¥68.87 Million ≈ $10.08 Million	0.086x	+9.84%
2014-12-31	CN¥735.64 Million ≈ $107.65 Million	CN¥57.35 Million ≈ $8.39 Million	0.078x	-63.23%
2013-12-31	CN¥350.14 Million ≈ $51.24 Million	CN¥74.23 Million ≈ $10.86 Million	0.212x	-42.12%
2012-12-31	CN¥285.34 Million ≈ $41.75 Million	CN¥104.50 Million ≈ $15.29 Million	0.366x	+18.31%
2011-12-31	CN¥225.51 Million ≈ $33.00 Million	CN¥69.81 Million ≈ $10.21 Million	0.310x	+12.70%
2010-12-31	CN¥170.81 Million ≈ $25.00 Million	CN¥46.92 Million ≈ $6.87 Million	0.275x	+26.99%
2009-12-31	CN¥103.18 Million ≈ $15.10 Million	CN¥22.32 Million ≈ $3.27 Million	0.216x	--

About Teyi Pharmaceutical Group Co Ltd

SHE:002728 China Drug Manufacturers - Specialty & Generic

Market Cap

$603.16 Million

CN¥4.12 Billion CNY

Market Cap Rank

#11445 Global

#3274 in China

Share Price

CN¥8.03

Change (1 day)

-1.11%

52-Week Range

CN¥8.03 - CN¥15.21

All Time High

CN¥129.24